Article
Transplacental mutagenicity of cisplatin: H-ras codon 12 and 13 mutations in skin tumors of SENCAR mice.
Carcinogenesis - 1 Dec 1996
Munoz E F, Diwan B A, Calvert R J, Weghorst C M, Anderson J, Rice J M, Buzard G S
Abstract excerpt
Cisplatin is an anticancer agent sometimes used in pregnant women. It is also a potent initiator of skin tumors in mice when administered transplacentally. For characterization of the transplacental mutagenicity of cisplatin, tumors initiated in fetal skin by cisplatin or 7,12-dimethylbenz[a]anthracene (DMBA) and promoted by postnatal 12-O-tetradecanoyl-phorbol-13-acetate (TPA) were analyzed for H-ras mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
